Skip to main content

Advertisement

Log in

MCM3 Protein Expression in Follicular and Classical Variants of Papillary Thyroid Carcinoma

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Minichromosome maintenance (MCM) proteins are needed as licensors in the DNA replication of eukaryotic cells and transcriptional control of MCM genes has critical role in the regulation of MCM functions. Different MCM protein family members are proposed as diagnostic or prognostic markers in various cancers due to their increased proliferative potential. Among MCM family members, minichromosome maintenance protein 3 (MCM3) expressions in both mRNA and protein levels were shown to be associated with papillary thyroid carcinoma (PTC). But, the usability of MCM3 in some histological variants of PTC might be controversial due to tissue specific molecular heterogeneities. In follicular variant of papillary thyroid carcinoma (FVPTC), a number of genes including MCM3 were shown to be differentially expressed which were specific to this kind of variant. Using immunohistochemistry method, MCM3 protein expression levels were compared in FVPTC, classic variant of papillary thyroid carcinoma (CVPTC), and multi-nodular goiter (MNG) tissues in a group of 32 cases. There was meaningful differences between MNG vs. FVPTC (p = 0.016) and MNG vs. CVPTC (p = 0.019) while there was no significant difference in the comparison FVPTC vs. CVPTC (p = 0.15). Four of the 5 CVPTC cases having surrounding tissue invasion had high expression values. For FVPTC and CVPTC, MCM3 protein expression results were parallel to our previous mRNA expression study while there was downregulation in protein expression despite the increased expression of MCM3 mRNA in MNG suggesting tissue-specific post-transcriptional events in benign thyroid neoplasms of which should be focused on. Moreover, the relatively lower MCM3 protein expression in FVPTC comparing to CVPTC could be due to a different tumorigenic pathway favored in this type of tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  2. Fagin JA, Mitsiades N (2008) Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 22:955–969

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Erickson L, Lloyd R (2010) Well-differentiated papillary thyroid carcinoma. In: Hunt J (ed) Molecular pathology of endocrine diseases. Springer, New York, pp 57–71

    Chapter  Google Scholar 

  4. Ertek S, Yilmaz NC, Cicero AF, Vurupalmaz O, Demiroz AS, Erdogan G (2012) Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers. Endocr Pathol 23:157–160

    Article  CAS  PubMed  Google Scholar 

  5. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255–1264

    Article  PubMed  Google Scholar 

  6. LiVolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24(Suppl 2):S1–S9

    Article  CAS  PubMed  Google Scholar 

  7. Salajegheh A, Petcu EB, Smith RA, Lam AK (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82

    Article  CAS  PubMed  Google Scholar 

  8. Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, Cengiz B, Gogebakan B, Cakmak EA, Demiryurek AT (2011) Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol 22:86–96

    Article  PubMed  Google Scholar 

  9. Tye BK (1999) MCM proteins in DNA replication. Annu Rev Biochem 68:649–686

    Article  CAS  PubMed  Google Scholar 

  10. Maine GT, Sinha P, Tye BK (1984) Mutants of S. cerevisiae defective in the maintenance of minichromosomes. Genetics 106:365–385

    CAS  PubMed  Google Scholar 

  11. Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE, Kim JW (2004) Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 10:8386–8395

    Article  CAS  PubMed  Google Scholar 

  12. Giaginis C, Vgenopoulou S, Vielh P, Theocharis S (2010) MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 25:351–370

    CAS  PubMed  Google Scholar 

  13. Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, Kwon HS, Cha BY, Kim JW (2010) Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Exp Mol Pathol 88:138–142

    Article  CAS  PubMed  Google Scholar 

  14. Lei M (2005) The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets 5:365–380

    Article  CAS  PubMed  Google Scholar 

  15. Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM (2007) Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol 14:3403–3411

    Article  PubMed  Google Scholar 

  16. Musahl C, Holthoff HP, Lesch R, Knippers R (1998) Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp Cell Res 241:260–264

    Article  CAS  PubMed  Google Scholar 

  17. Endl E, Kausch I, Baack M, Knippers R, Gerdes J, Scholzen T (2001) The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. J Pathol 195:457–462

    Article  CAS  PubMed  Google Scholar 

  18. Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K (2006) Cancer stem cell hypothesis in thyroid cancer. Pathol Int 56:485–489

    Article  CAS  PubMed  Google Scholar 

  19. Shibru D, Chung KW, Kebebew E (2008) Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol 20:13–18

    Article  CAS  PubMed  Google Scholar 

  20. Salabe GB (2001) Pathogenesis of thyroid nodules: histological classification? Biomed Pharmacother 55:39–53

    Article  CAS  PubMed  Google Scholar 

  21. Madine MA, Swietlik M, Pelizon C, Romanowski P, Mills AD, Laskey RA (2000) The roles of the MCM, ORC, and Cdc6 proteins in determining the replication. J Struct Biol 129:198–210

    Article  CAS  PubMed  Google Scholar 

  22. Zhu M, Wang F, Yan F, Yao PY, Du J, Gao X, Wang X, Wu Q, Ward T, Li J, Kioko S, Hu R, Xie W, Ding X, Yao X (2008) Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization. J Biol Chem 283:18916–18925

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Erhan Yengil for his statistical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusuf Ziya Igci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Igci, Y.Z., Erkilic, S., Igci, M. et al. MCM3 Protein Expression in Follicular and Classical Variants of Papillary Thyroid Carcinoma. Pathol. Oncol. Res. 20, 87–91 (2014). https://doi.org/10.1007/s12253-013-9662-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9662-9

Keywords

Navigation